Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction

A clear consensus does not exist about whether the initial dose of gemcitabine, an essential anticancer antimetabolite, should be reduced in patients with liver dysfunction. Adult patients with biliary tract or pancreatic cancer were divided into three groups according to whether they had mild, mode...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Sci
Main Authors: Shibata, Takashi, Ebata, Tomoki, Fujita, Ken‐ichi, Shimokata, Tomoya, Maeda, Osamu, Mitsuma, Ayako, Sasaki, Yasutsuna, Nagino, Masato, Ando, Yuichi
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2016
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768397/
https://ncbi.nlm.nih.gov/pubmed/26595259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12851
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items